To include your compound in the COVID-19 Resource Center, submit it here.

Cancer

INDICATION: Lymphoma; breast cancer; colorectal cancer

Mouse studies suggest intratumoral injection of a TLR9 agonist and an agonist antibody against OX40 could help treat lymphoma, breast cancer and colorectal cancer. In a mouse model of

Read the full 344 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE